Urinary bladder cancer: biomarkers and target therapy, new era for more attention

• Autors principals: Amrallah A. Mohammed (Autor), Hani EL-Tanni (Autor), Hani M. EL-Khatib (Autor), Ahmad A. Mirza (Autor), Abdulrahim A. Mirza (Autor), Turki H. Alturaifi (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2016-12-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Currently, bladder cancer (BCa) evaluation depends mainly on traditional clinicopathological parameters encompassing tumor stage and grade, which will not reflect the behavior of the disease. Diverse molecular alterations are responsible for the heterogeneous course. The differences in molecular pat...